# Radiolabeled Monoclonal Antibody in Treating Patients With Advanced Ovarian Epithelial Cancer

> **NCT00072410** · PHASE1 · COMPLETED · sponsor: **Ludwig Institute for Cancer Research** · enrollment: 7 (actual)

## Conditions studied

- Ovarian Cancer

## Interventions

- **BIOLOGICAL:** 90Y-hu3S193
- **BIOLOGICAL:** 111In-hu3S193

## Key facts

- **NCT ID:** NCT00072410
- **Lead sponsor:** Ludwig Institute for Cancer Research
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-11
- **Primary completion:** 2005-05
- **Final completion:** 2006-11-15
- **Target enrollment:** 7 (ACTUAL)
- **Last updated:** 2023-10-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00072410

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00072410, "Radiolabeled Monoclonal Antibody in Treating Patients With Advanced Ovarian Epithelial Cancer". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00072410. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*